2024-11-20 19:38:27
AffaMed Therapeutics Announces Approval for the Phase IIb Clinical Study of AM006 in China for the Treatment of Parkinson's Disease
Health/ 2023-07-22
AffaMed Therapeutics Announces Approval ...

SHANGHAI,May 28,2021-- AffaMed Therapeutics ("AffaMed"),a global clinical stage biopharmaceutical company dedicated to addressing ...

Antengene Announces First Patient Dosed in Phase I/II Trial of Eltanexor for the Treatment of Myelodysplastic Syndrome
Corporate/ 2023-07-23
Antengene Announces First Patient Dosed ...

SHANGHAI and HONG KONG,May 28,2021-- Antengene Corporation Limited ("Antengene",SEHK: 6996.HK),a leading innovative biopharmaceuti...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release